| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -2.0 | — |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-Q filed with the SEC, NASDAQ: RACC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Research Alliance Corp III: key numbers
- Share price
- $10.12Close, Nov 16
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.